Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2008SLEEPOpen Access

Long-Term Efficacy and Safety of Zolpidem Extended-Release 12.5 mg, Administered 3 to 7 Nights Per Week for 24 Weeks, in Patients With Chronic Primary Insomnia: A 6-Month, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study

View Full Paper
Ask AI
Bookmark
Share

Authors

AKAndrew D. KrystalUniversidad Católica de Santa FeMEMilton K. ErmanBoston UniversityGZGary ZammitNorthwestern University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Krystal et al. (2008) studied this question.

synapsesocial.com/papers/6a76379d1ce449dc42709dc9https://doi.org/10.1093/sleep/31.1.79
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Variability and predictability in sleep patterns of chronic insomniacs2005 · 125 citations
  2. 2Epidemiological Study on Insomnia in the General Population1996 · 399 citations
  3. 3Eight Weeks of Non-Nightly Use of Zolpidem for Primary Insomnia2000 · 158 citations
  4. 4Long-Term, Non-Nightly Administration of Zolpidem in the Treatment of Patients With Primary Insomnia2004 · 144 citations